This study is undertaken to design zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator (t-PA) for thrombolytic therapy where the t-PA activity can be recovered in the blood circulation upon ultrasound irradiation. Various molecular weights of gelatin were complexed with t-PA by their simply mixing in aqueous solution. Then, zinc acetate, calcium acetate or magnesium acetate was added to form nano-sized gelatint-PA complexes. The complexes had the apparent molecular size of about 100 nm. When zinc ions were added to the gelatint-PA complexes, the t-PA activity was suppressed most strongly to 57% of the original, free t-PA activity. Upon ultrasound exposure in vitro, the t-PA activity was fully recovered. A cell culture experiment with L929 fibroblasts demonstrated no cytotoxicity of complexes at the concentration used for the in vivo experiment. The half-life of t-PA in the blood circulation prolonged by the complexation with gelatin and zinc ions. The zinc-stabilized t-PAgelatin complex is a promising t-PA delivery system which can manipulate the thrombolytic activity by the local ultrasound irradiation.
INTRODUCTION

1
In acute myocardial infarction, treatment strategies aimed at rapidly restoring complete and 2 persistent coronary flow, and the recanalisation of infarct artery is the target of both 3 pharmacological and mechanical reperfusion techniques. Tissue-type plasminogen activator 4 (t-PA) is widely used as a thrombolytic drug because of its high fibrin specificity (Armstrong  5 Collen, 2001 ) and efficacy if administered early. However, t-PA has some adverse effects to be 6 clinically resolved, including the risk of allergic reactions, bleeding complications, and short 
Preparation of t-PA complexes with gelatin and metal ions 1
To prepare the complexes of t-PA and gelatin, 10 mg of gelatin with different molecular 2 weights in 10 mM phosphate-buffered solution (PBS, pH 7.4) (0.25 ml) was mixed with 0.5 ml 3 of PBS containing 0.5 mg of t-PA. After agitation at 37°C for 30 min, different concentrations 4 of zinc acetate, magnesium acetate, or calcium acetate (0.25 ml) were added to the mixture, 5
followed by agitation at 37°C for 30 min to prepare the complex of t-PA with gelatin and metal 6 ions. 7 8
Measurement of apparent molecular size of t-PA complexes with gelatin and zinc ions 9
The apparent molecular size of t-PA complexes with gelatin and zinc ions was measured by 10 dynamic light scattering (DLS) apparatus (DLS-7000, Otsuka Electronic, Osaka, Japan) 11 equipped with an Ar + laser at a detection angle of 90° at 37°C. The autocorrelation function of 12 samples was analyzed based on the histogram method and R s value was calculated 13 automatically by the equipped computer software. The experiments were done 3 times 14 independently for each sample. 15 
16
Assay of t-PA activity by fibrin plate method 17
To determine the in vitro thrombolytic activity of t-PA, a fibrin clot lysis assay was 18 performed according to the conventional plasminogen-rich fibrin plate method (Astrup and 19 Müllertz, 1952) . Briefly, 0.4 wt% human fibrinogen solution (10 ml) in 0.17 M borate buffer 20 7 independently for each sample. 1
Body distribution tests of t-PA complexes with gelatin and zinc ions 3
The body distribution of complexes of t-PA with gelatin and zinc ions was evaluated for 4 6-week-old female ddY mice (Simizu Laboratory Supplies Co., Ltd., Kyoto, Japan) as 5 described previously (Kushibiki et al., 2004b) . Briefly, t-PA was radioiodinated according to 6 the chloramine T method (Wilbur et al., 1989) . The t-PA complexes were similarly prepared by 7 the procedure described above other than using 125 I-labeled t-PA. The 125 I-labeled t-PA and the 8 complexes with gelatin and zinc ions were administered into the tail vein of mice in a PBS 9 volume of 100 l. At different time intervals after administration, the blood samples were 10 collected from the eye orbit. The radioactivity of blood was counted on the gamma counter 11 (ARC-301B, Aloka, Tokyo, Japan). The percentage of radioactivity remaining was expressed 12 as 100% for the radioactivity of t-PA initially administrated. 13 At 60 min after administration, the mice were sacrificed and their tissues and organs were 14 excised and rinsed quickly with cold water to remove the surface blood. Then, the radioactivity 15 of tissues and organs was counted as described above. The animal experiments were carried out 16 according to the Institutional Guidance of Kyoto University on Animal Experimentation. The 17 experiment was done 6 times independently for each sample at each time point. 18 
19
Statistical analysis 20
The statistical analysis was performed using an unpaired Student's t test. All the data were 21 presented as the mean  the standard deviation (SD). 
RESULTS
1
Characterization of t-PA complexes with gelatin and zinc ions 2 Figure 1 shows the apparent molecular size of gelatin with different molecular weights, the 3 complexes of t-PA and zinc ions. The apparent molecular size of gelatins with molecular 4 weights ranging from 2,000 to 5,000 could not be measured because of their too small size. The 5 molecular weight size of gelatin tended to increase with the increased molecular weight. The 6 apparent molecular size of gelatin was increased by the addition of zinc ions. Irrespective of the 7 molecular weight of gelatin, the apparent molecular size was dramatically changed by mixing 8 with t-PA and zinc ions. The size of t-PA complexes tended to decrease with an increase in the 9 molecular weight of gelatin. 10 
11
Thrombolytic activity of t-PA complexes with gelatin and zinc ions 12 Figure 2 shows the t-PA activity change by the complexation with gelatin of different 13 molecular weights and zinc ions. Irrespective of the gelatin molecular weight, the thrombolytic 14 activity of t-PA was significantly suppressed by the complexation with gelatin and zinc ions 15 ( Figure 2A ). The suppression tended to become stronger with a decrease in the molecular 16 weight of gelatin. Figure 2B shows the t-PA activity change of complexes with gelatins and 17 zinc ions in the presence of BSA. Interestingly, the suppression was weaker with a decrease in 18 the molecular weight of gelatin. From the viewpoint of activity suppression, the following 19 experiment was performed for the gelatin with a molecular weight of 100,000. Figure 3 shows 20 change in the t-PA activity by complexing with zinc ions and gelatin at different concentrations. 21 The activity of t-PA complexes tended to decrease with an increase in the concentration ofgelatin, and then leveled off at the gelatin concentrations of 10 mg/ml and higher. When 23 fractionated by a gel filtration column, the t-PA containing ratio of t-PA complexes at theEffect of metal ions on thrombolytic activity of t-PA complexes with gelatin 1 Figure 4 shows the activity change of t-PA by complexation with gelatin and various types 2 of metal ions. The t-PA activity was significantly suppressed by complexing with gelatin and 3 every metal ions tested in this study ( Figures 4A-C) , although the t-PA activity was not 4 suppressed by complexation with gelatin alone (data not shown). The suppression extent 5 increased in a dose-dependent manner. Among zinc, magnesium, and calcium ions, the 6 thrombolytic activity of complexes was suppressed most strongly with zinc ions. In addition, 7 the stability of t-PA complexes with magnesium and calcium ions in serum was lower than that 8 with zinc ions (data not shown). After ultrasound exposure, the suppressed t-PA activity of 9 gelatin and zinc ions complexes was recovered to the level of original t-PA activity at the zinc 10 concentrations of 5 mM or lower ( Figure 4D ). 11 Figure 5 shows the activity of t-PA in the presence of zinc ions at different concentrations. No decrease in the t-PA activity was observed at the zinc concentrations of 5 mM and lower. However, the cell viability gradually decreased at the concentrations of 300 g/ml and higher.g/ml, 50 g/ml and lower, respectively (Figures 7B, C). The concentration of zinc 23 ions, gelatin, and t-PA used for complexation in the in vivo experiment were 2 M, 4 g/ml, 24 and 0.2 g/ml, respectively, which is much lower than those of cytotoxicity. 25 Figure 8A shows the percentage of radioactivity remaining in the blood circulation 2 following intravenous administration of 125 I-labeled t-PA and the complexes. The radioactivity 3 remaining was significantly higher for the complexes of gelatin and zinc ions than that of free 4 t-PA over the time range studied. The blood concentration of free t-PA was rapidly reduced 5 after administration. Complexation with gelatin and zinc ions prolonged the blood half-life of 6 t-PA about 3 times. Figure 8B shows the tissue distribution of t-PA complexes with gelatin and 7 zinc ions or free t-PA. The similar body distribution pattern was observed between the two 8 groups. This study is undertaken to design a novel ultrasound-responsive t-PA delivery system with 10 gelatin and zinc ions. Gelatin has been used for the controlled release of various drugs, proteins, 11
Body distribution of t-PA and t-PA complexes with gelatin and zinc ions 1
and genes because of the good biodegradability and biocompatibility (Veis, 1965 The thrombolytic activity of t-PA was suppressed by the complexation with gelatin and zinc 15 ions under the optimal condition, and recovered only when exposed to ultrasound. This 16 ultrasound-induced recovery of t-PA activity is an ideal system considering several problems to 17 be resolved clinically, such as the bleeding complication and the short half-life in vivo. . These results suggested that the interaction of t-PA and gelatin molecules for 1 complexation was stronger than that of specific interaction between the CBD and the collagen 2 peptide. However, the t-PA activity was not suppressed by complexation with gelatin (data not 3 shown). It is highly conceivable that the t-PA molecules do not always interact with gelatin in 4 the manner to biologically suppress the t-PA activity. Therefore, metal ions were added to 5 modify the interaction between the gelatin and t-PA molecles. 6
The analysis on the nonredundant proteins structures from the Protein Data Bank showed 7 that the most abundant metal ion in the body is ions. The apparent molecular size of gelatin was dramatically changed by t-PA and Zn 2+ ions 14 complexation. It tended to increase with a decrease in the molecular weight ( Figure 1 ). The 15 thrombolytic activity of t-PA tended to suppress more strongly by the complexion with gelatin 16 and zinc ions when the molecular weight of gelatin decreased (Figure 2A ). The SDS-PAGE 17 analysis and atomic absorption photometer revealed that the complexes of gelatin and t-PA, 18 when fractionated by a gel filtration column, were contained zinc ions (data not shown). 19 Moreover, no decrease in the t-PA activity was observed at the zinc concentrations of 5 mM and 20 lower ( Figure 5 ). With gelatin molecules, the t-PA activity was suppressed at low 21 concentrations of zinc ions, although the t-PA activity was maintained without gelatin. 22
Additionally, the suppression extent of t-PA activity tended to increase with an increase in the 23 concentration of gelatin (Figure 3 ). Taken together, we can say with certainty that the 24 interaction between the t-PA and gelatin molecules can be reinforced by mixing zinc ions,resulting in the suppressed biological activity. The amino acid residues contributing to the 1 coordination bonds with zinc ions are Cys, His, Asp, and Glu in the metalloproteins (Dokmanić 2 et al., 2008) . For the present t-PA complexes, the carboxyl, hydroxyl, and amino groups of 3 gelatin and t-PA were considered to contribute to the coordination bond with zinc ions, while 4 the carboxyl groups also contribute to the ionic bond. Taken together, it is highly speculated 5 that t-PA molecules electrostatically interact with gelatin ones to form their complex, and 6 additionally, the complex becomes stable through the coordination bond with zinc ions 7 between the carboxyl, hydroxyl, and amino groups of the two proteins. 8
The t-PA activity of complexes depended on the molecular weight of gelatin used ( Figure  9 2). This can be explained by the mobility of gelatin molecules. The molecular mobility of 10 lower molecular weight gelatin to interact is high compared with that of higher molecular 11 weight gelatin. Therefore, it is highly conceivable that the t-PA molecules of negative charge 12 interact more with smaller gelatin molecules of positive charge, resulting in the larger 13 molecular size of t-PA complexes (Figure 1 ). The more interaction would cover t-PA molecules 14 more to suppress the activity to a higher extent (Figure 2A) . However, the effect of gelatin 15 molecular weight on the t-PA activity in the presence of BSA was different. The smaller gelatin 16
showed the higher percent t-PA activity ( Figure 2B ). This suggests that the BSA presence 17 enabled the t-PAgelatin complexes to dissociate. The electrostatic interaction between smaller 18 gelatin and t-PA molecules is weaker than that of larger gelatin ones. In addition, the smaller 19 gelatin molecules have the higher mobility. As the result, it is likely that small gelatin are 20 readily detached from the t-PA molecules and bound to BSA ones. On the other hand, it is 21 demonstrated that albumin has a high-affinity zinc binding site consisting of His67 and Asn99 22 from domain I and His247 and Asp249 from domain II (Lu et al., 2008; Stewart et al., 2003) . 23
This binding may allow the gelatin and BSA interaction to stabilize, resulting in the increasedmolecular weight of gelatin 100,000 was selected for the t-PA complexes formation. 1
It is apparent in Figure 4D that the ultrasound irradiation allowed the t-PA activity to recover 2 to the original level. This is because the interaction forces between the t-PA and gelatin 3 molecules in the presence of zinc ions were not so strong to allow dissociation by the 4 ultrasound stimulus. In addition, the ultrasound irradiation did not lose the t-PA activity. In this 5 study, the conditions of ultrasound were a frequency of 1 MHz and an intensity of 0.75 W/cm Zn ions used for complexation in the in vivo experiment were 0.2 g/ml, 4 g/ml, and 2 M, 22 respectively, which is much lower than those of cytotoxicity. At the concentration of t-PA, 23 gelatin, or Zn ions alone, no cytotoxicity was observed. It is conceivable that upon ultrasoundthat the combination of components brings about any cytotoxicity. Therefore, we believe that 1 the t-PA complexes with gelatin and Zn ions after the application of ultrasound irradiation have 2 no cytotoxicity in the in vivo experiment. 3
The t-PA used in this study is mutant t-PA, monteplase (Verstraete, 1999 is highly speculated that the ultrasound power dissociates the interaction of t-PA and gelatin 13 complexes by cavitation effect which generates shock waves and high-speed fluid microjets 14 (Deckers et al., 2008) . From the data comparison, we can say that our delivery system is a 15 sensitive and effective ultrasound-responsive system. For the t-PA complexes at the optimal 16 concentration of zinc ions, the t-PA activity could be recovered by ultrasound irradiation. In the 17 previous study, free t-PA administration with or without ultrasound was effective in 18 recanalization, although there were the adverse effects to be resolved (Kawata et al. In the investigations, it is suggested that the direct transmission of energy and the acousticcavitation with low-frequency and high-intensity ultrasound broke clots into small fragments 1 (Rosenschein et al., 1994) , promote the penetration of t-PA molecules into the thrombus, the 2 radiation force to facilitate the reformation, and opening of fibrin matrix, and enhance the drug 3 diffusion, and the direct effects on the binding of t-PA to the fibrin clot are the mechanisms of 4 ultrasound on the enhanced thrombolysis (Tiukinhoy-Laing et al., 2007) . In the future, we plan 5 further studies of evaluation of the thrombolytic effect of t-PA complexes with or without the 6 local ultrasound irradiation around the infarction site of blood vessels in rabbit and swine 7 thrombosis models. 8
9
CONCLUSION
10
Novel and promising ultrasound-responsive nano gelatin complexes of t-PA stabilized by 11 zinc ions were designed. This system is safe, simple, and convenient to permit the treatment of 12 acute myocardial infarction while performing diagnosis at the same time even in emergency 13 conditions. Moreover, the delivery system is also applicable to other therapeutic drugs for the 14 medical treatment of various diseases. t-PA activity was expressed as 100% for free t-PA without zinc ions.  P < 0.05; significant 20 against the activity of free t-PA (t-PA). 21 concentrations. The percent t-PA activity was expressed as 100% for free t-PA without zinc 24 ions.  P < 0.05; significant against the activity of free t-PA. Figure 6 . Effect of EDTA addition on the t-PA activity of complexes with gelatin (Mw = 1 100,000, 10 mg/ml) and zinc ions (5 mM). The percent t-PA activity was expressed as 100% for 2 free t-PA without zinc ions.  P < 0.05; significant against the activity of free t-PA. 
